Factors Associated With Patient and Graft Survival Using Kidneys From Cadaveric Donors in Transplanted Patients Over 18 Years of Age in Argentina

被引:5
作者
Bisigniano, L. [1 ]
Lopez-Rivera, A. [1 ]
Tagliafichi, V. [1 ]
Fernandez, V. [1 ]
Soratti, C. [1 ]
机构
[1] Minist Hlth, Sci Tech Off, INCUCAI, Natl Inst Procurement & Transplantat Argentina, RA-1428 Buenos Aires, DF, Argentina
关键词
RENAL-TRANSPLANTATION; CYCLOSPORINE; RECIPIENTS;
D O I
10.1016/j.transproceed.2012.07.117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. With improvements in short-term kidney graft and patient survival, focus has shifted to understand patient and graft features that affect long-term survival. Materials and methods. This retrospective analysis from January 1998 to December 2009 employed Kaplan-Meier analysis to evaluate survival ratios at 30 days as well as 1, 5, and 10 years. A multivariable Cox regression model considered variables of donor and recipient, gender and age, cold ischemia time (CIT), chronic renal failure etiology, time on dialysis (TD) and cause of donor death. The mismatch (MM) value was coded according to the number of antigens shared by both the donor and the recipient for HLA-A, B, and DR. The MM values ranged between 0 and 6. Two groups were analyzed according the number of shared antigens: 0 to 3 versus 4 to 6. Results. Among 3030(55.85%) males and 2395 (44.15%) females, the overall mean age was 46.9 +/- 13.9 years. Median follow-up was 4 years (max 13 years). Patient survival rate (SR) was 97.5% at 30 days, 87.5% at 1 year, 74.5% at 5 years, and 59.2% at 10 years. Using Cox analysis, patient SR was affected by: diabetic nephropathy (DN) hazard ratio (HR) 1.55 (95% confidence interval [CI 95%] 1.21-1.97) P = .0005; head trauma (HT) cause of donor death HR 0.83 (0.73-0.95) P = .0005 and donor age (DA) compared by 18 to 44 years: 45 to 59 years HR 1.44 (CI95% 1.00-1.30) P = .043, >60 years HR 1.41 (CI95% 1.17-1.70) P = .0004. In addition relevant factors were recipient age (RA) compared by 18 to 44 years: 45 to 59 HR 1.99 (CI95% 1.74-2.27) P <. 0001, >60 years HR 3.24 (CI95% 2.79-3.75) P < .0001 and DT >7 years HR 1.33 (CI95% 1.19-1.48) P = .0001. MM HLA 0 to 3 level HR 0.78 (CI95% 0.69-0.88) P < .0001. Graft SR was 95% at 30 days, 81.6% at 1 year, 64.7% at 5 years, and 47.3% at 10 years. The relevant factors were: DN HR 1.26 (CI95% 1.01-1.57) P = .04; HT HR 0.82 (0.74-0.91) P = .0004; DA compared by 18 to 44 years: 45-59 years HR 1.19 (CI95% 1.07-1.32) P = .002, >60 years HR 1.53 (CI95% 1.30-1.80) P < .0001; RA compared by 18 to 44 years: 45-59 BR 1.33 (CI95% 1.19-1.47) P < .0001, >60 years HR 1.84 (CI95% 1.63-2.09) P < .0001; DT >7 years HR 1.22 (CI95% 1.11-1.35) P = .0001; CIT >24 hours HR 1.13 (CI95% 1.03-1.23) P = .009 and MM HLA 0 to 3 HR 0.82 (CI95% 0.74-0.91) P = .0002. Conclusion. HT as the cause of donor death and MM between 0 and 3 were associated with better patient and graft SR, DN, TD over 7 years, DA and RA over 45 were associated with lower patient SR. CIT > 24 hours, DN, TD over 7 years, as well as donor and recipient ages over 45 yr were associated with a lower graft SR.
引用
收藏
页码:2242 / 2245
页数:4
相关论文
共 10 条
[1]   Improved graft survival after renal transplantation in the United States, 1988 to 1996. [J].
Hariharan, S ;
Johnson, CP ;
Bresnahan, BA ;
Taranto, SE ;
McIntosh, MJ ;
Stablein, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :605-612
[2]   Risk factors for renal allograft survival from older cadaver donors [J].
Hariharan, S ;
McBride, MA ;
Bennett, LE ;
Cohen, EP .
TRANSPLANTATION, 1997, 64 (12) :1748-1754
[3]   EXPERIENCES WITH RENAL HOMOTRANSPLANTATION IN THE HUMAN - REPORT OF 9 CASES [J].
HUME, DM ;
MERRILL, JP ;
MILLER, BF ;
THORN, GW .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (02) :327-382
[4]   A study of the quality of life and cost-utility of renal transplantation [J].
Laupacis, A ;
Keown, P ;
Pus, N ;
Krueger, H ;
Ferguson, B ;
Wong, C ;
Muirhead, N .
KIDNEY INTERNATIONAL, 1996, 50 (01) :235-242
[5]   CYCLOSPORINE - 5 YEARS EXPERIENCE IN CADAVERIC RENAL-TRANSPLANTATION [J].
MERION, RM ;
WHITE, DJG ;
THIRU, S ;
EVANS, DB ;
CALNE, RY .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (03) :148-154
[6]   Effect of human leukocyte antigen compatibility on kidney graft survival:: Comparative analysis of two decades [J].
Opelz, Gerhard ;
Doehler, Bernd .
TRANSPLANTATION, 2007, 84 (02) :137-143
[7]   A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation [J].
Pirsch, JD ;
Miller, J ;
Deierhoi, MH ;
Vincenti, F ;
Filo, RS .
TRANSPLANTATION, 1997, 63 (07) :977-983
[8]   The effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups [J].
Roberts, JP ;
Wolfe, RA ;
Bragg-Gresham, JL ;
Rush, SH ;
Wynn, JJ ;
Distant, DA ;
Ashby, VB ;
Held, PJ ;
Port, FK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06) :545-551
[9]   MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS [J].
SOLLINGER, HW .
TRANSPLANTATION, 1995, 60 (03) :225-232
[10]   Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. [J].
Wolfe, RA ;
Ashby, VB ;
Milford, EL ;
Ojo, AO ;
Ettenger, RE ;
Agodoa, LYC ;
Held, PJ ;
Port, FK .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (23) :1725-1730